Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 A Hong Kong influenza immunity three years after immunization.

× No keyword cloud information.

10 in total

1. Time to earliest peak serum antibody response to influenza vaccine in the elderly.

Authors: P A Gross; C Russo; S Dran; P Cataruozolo; G Munk; S C Lancey
Journal: Clin Diagn Lab Immunol Date: 1997-07

2. Timeliness of pediatric influenza vaccination compared with seasonal influenza activity in an urban community, 2004-2008.

Authors: Annika M Hofstetter; Karthik Natarajan; Daniel Rabinowitz; Raquel Andres Martinez; David Vawdrey; Stephen Arpadi; Melissa S Stockwell
Journal: Am J Public Health Date: 2013-05-16 Impact factor: 9.308

3. Use of temperature-sensitive mutants of influenza A virus as live virus vaccine strains. Evaluation in laboratory animals, adults and children.

Authors: B R Murphy; D D Richman; S B Spring; R M Chanock
Journal: Postgrad Med J Date: 1976-06 Impact factor: 2.401

4. Durability of antibody responses after receipt of the monovalent 2009 pandemic influenza A (H1N1) vaccine among HIV-infected and HIV-uninfected adults.

Authors: Nancy F Crum-Cianflone; Erik Iverson; Gabriel Defang; Patrick J Blair; Lynn E Eberly; Jason Maguire; Anuradha Ganesan; Dennis Faix; Christopher Duplessis; Tahaniyat Lalani; Timothy Whitman; Carolyn Brandt; Grace Macalino; Eugene V Millar; Timothy Burgess
Journal: Vaccine Date: 2011-03-01 Impact factor: 3.641

5. Time to peak serum antibody response to influenza vaccine in the elderly.

Authors: P A Gross; C Russo; M Teplitzky; S Dran; P Cataruozolo; G Munk
Journal: Clin Diagn Lab Immunol Date: 1996-05

6. Protection by a polyvalent influenza vaccine and persistence of homologous and heterologous HI antibodies during a period of two epidemic seasons.

Authors: R Pyhälä
Journal: J Hyg (Lond) Date: 1980-04

7. Relationship between surface antigens of two variants of influenza A (H3N2) virus, as revealed by hemagglutination inhibition, kinetic neutralization, and neuraminidase inhibition.

Authors: C N Hsia; H M Foy; M K Cooney
Journal: Infect Immun Date: 1980-11 Impact factor: 3.441

8. Immunity to attenuated influenza virus WRL 105 infection induced by heterologous, inactivated influenza A virus vaccines.

Authors: C W Potter; R Jennings; K Nicholson; D A Tyrrell; K G Dickinson
Journal: J Hyg (Lond) Date: 1977-12

9. A cell culture-derived influenza vaccine provides consistent protection against infection and reduces the duration and severity of disease in infected individuals.

Authors: Hartmut J Ehrlich; Julia Singer; Gregory Berezuk; Sandor Fritsch; Gerald Aichinger; Mary Kate Hart; Wael El-Amin; Daniel Portsmouth; Otfried Kistner; P Noel Barrett
Journal: Clin Infect Dis Date: 2012-01-19 Impact factor: 9.079

10. Seasonal influenza vaccine effectiveness among children, 2010-2012.

Authors: Chuanxi Fu; Qing He; Zhaotian Li; Jianxiong Xu; Yongqian Li; Jianyun Lu; Kuibiao Li; Qiongying Yang; Zhiqiang Dong; Xiangyi Liu; Sijun Wen; Wensui Hu; Danfeng Zhang; Jiayun Lv; Wei Zhu; Ming Wang
Journal: Influenza Other Respir Viruses Date: 2013-08-26 Impact factor: 4.380

10 in total